These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 27991834)

  • 1. Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.
    dosReis S; Park A; Ng X; Frosch E; Reeves G; Cunningham C; Janssen EM; Bridges JFP
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):234-242. PubMed ID: 27991834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?
    Ng X; Bridges JF; Ross MM; Frosch E; Reeves G; Cunningham CE; dosReis S
    Patient; 2017 Apr; 10(2):251-262. PubMed ID: 27798814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.
    dosReis S; Ng X; Frosch E; Reeves G; Cunningham C; Bridges JF
    Patient; 2015 Oct; 8(5):423-31. PubMed ID: 25392024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.
    Schatz NK; Fabiano GA; Cunningham CE; dosReis S; Waschbusch DA; Jerome S; Lupas K; Morris KL
    Patient; 2015 Dec; 8(6):483-97. PubMed ID: 25644223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care Management for Youth With Comorbid Developmental and Mental Health Conditions: A Discrete Choice Experiment Pilot Study.
    dosReis S; N'Dri L; Ross M; Camelo Castillo W; Reeves G; Butler B
    Acad Pediatr; 2020 Mar; 20(2):241-249. PubMed ID: 31128382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children.
    Ross M; Bridges JF; Ng X; Wagner LD; Frosch E; Reeves G; dosReis S
    Psychiatr Serv; 2015 Feb; 66(2):208-11. PubMed ID: 25642618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.
    Faraone SV; Schachar RJ; Barkley RA; Nullmeier R; Sallee FR
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):715-722. PubMed ID: 28394175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.
    Sallee FR
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):558-65. PubMed ID: 26151738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caregivers' Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children.
    Ross M; Nguyen V; Bridges JFP; Ng X; Reeves G; Frosch E; dosReis S
    J Dev Behav Pediatr; 2018; 39(2):93-100. PubMed ID: 29461996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of parents' preferences for the treatment of school-age children with ADHD: a discrete choice experiment.
    Fegert JM; Slawik L; Wermelskirchen D; Nübling M; Mühlbacher A
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):245-52. PubMed ID: 21671692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.
    van der Kolk A; Bouwmans CA; Schawo SJ; Buitelaar JK; van Agthoven M; Hakkaart-van Roijen L
    J Ment Health Policy Econ; 2014 Sep; 17(3):119-29. PubMed ID: 25543115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Caregiver Perspective on Paediatric ADHD (CAPPA) survey: Understanding sociodemographic and clinical characteristics, treatment use and impact of ADHD in Europe.
    Flood E; Gajria K; Sikirica V; Dietrich CN; Romero B; Harpin V; Banaschewski T; Quintero J; Erder MH; Fridman M; Chen K
    J Affect Disord; 2016 Aug; 200():222-34. PubMed ID: 27137089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder.
    Dosreis S; Zito JM; Safer DJ; Soeken KL; Mitchell JW; Ellwood LC
    J Dev Behav Pediatr; 2003 Jun; 24(3):155-62. PubMed ID: 12806227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
    Martens MA; Seyfer DL; Andridge RR; Foster JE; McClure KE; Coury DL
    Res Dev Disabil; 2013 May; 34(5):1700-9. PubMed ID: 23500164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial.
    Myers K; Vander Stoep A; Zhou C; McCarty CA; Katon W
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):263-74. PubMed ID: 25791143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.